• Our products

  • 1


VIMPAT® (Lacosamide) is an antiepileptic drug approved as adjunctive therapy for partial-onset seizures. Vimpat is a functionalized amino acid, the antiepileptic effects of which appear to be due to a novel mode of action, namely the selective enhancement of slow inactivation of voltage-gated sodium channels.

NEUPRO® (Rotigotine Transdermal System) is a dopamine agonist that works by helping to restore the balance of dopamine in the brain. Neupro is indicated for the treatment of the signs and symptoms of early-stage idiopathic Parkinson’s disease as monotherapy (i.e. without levodopa) or in combination with levodopa, i.e. over the course of the disease, through to late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or “on-off” fluctuations).

*for full prescribing information please refer to your locally approved label*


  • 1